Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471698) titled 'hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease' on March 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Help Therapeutics
Condition:
Ischemic Heart Failure
CABG-patients
Intervention:
Drug: HiCM-188 Chitosan Patch
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: October 20, 2026
Target Sample Size: 16
Countries of Recruitment:
China
To know more, v...